XiZang XiNian Communication Technology Co., Ltd. – Trademark Portfolio

Entity Type: 16

XiZang XiNian Communication Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. The owner is based in XiZang.

701,BLK.A,No.7LinQiongGang East Rd.Lhasa

Economic&Technological Development Zone

XiZang , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

REDBIRD
REDBIRD
Cancelled 2017
REDBIRD
REDBIRD
Cancelled 2017

Trademark Classifications

XiZang XiNian Communication Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does XiZang XiNian Communication Technology Co., Ltd. have?

XiZang XiNian Communication Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO.

What trademark classes does XiZang XiNian Communication Technology Co., Ltd. file in?

XiZang XiNian Communication Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What is XiZang XiNian Communication Technology Co., Ltd.'s trademark registration success rate?

XiZang XiNian Communication Technology Co., Ltd. has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.